BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 38069452)

  • 1. Early identification of macrophage activation syndrome secondary to systemic lupus erythematosus with machine learning.
    Lin W; Xie X; Luo Z; Chen X; Cao H; Fang X; Song Y; Yuan X; Liu X; Du R
    Arthritis Res Ther; 2024 May; 26(1):92. PubMed ID: 38725078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring Macrophage Activation Syndrome Secondary to Systemic Lupus Erythematosus in Adults: A Systematic Review of the Literature.
    Aziz A; Castaneda EE; Ahmad N; Veerapalli H; Rockferry AG; Lankala CR; Hamid P
    Cureus; 2021 Oct; 13(10):e18822. PubMed ID: 34804679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Diagnostic Radiological Imaging Modalities to Explore Neurological Dysfunction and Renal Failure in the Intersection of Hemophagocytic Lymphohistiocytosis, Macrophage Activation Syndrome, and Lupus.
    Cazzaniga J; Georgiyeva K; Siguenza A; Gonzalez T; Ferraro P
    Cureus; 2024 Feb; 16(2):e54005. PubMed ID: 38496127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical characteristics and diagnostic indicators of macrophage activation syndrome in patients with systemic lupus erythematosus and adult-onset Still's disease].
    Yao HH; Yang F; Tang SM; Zhang X; He J; Jia Y
    Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):966-974. PubMed ID: 38101776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical spectrum and therapeutic management of systemic lupus erythematosus-associated macrophage activation syndrome: a study of 20 Moroccan adult patients.
    Wafa A; Hicham H; Naoufal R; Hajar K; Rachid R; Souad B; Mouna M; Zoubida MT; Mohamed A
    Clin Rheumatol; 2022 Jul; 41(7):2021-2033. PubMed ID: 35179662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arthritis and use of hydroxychloroquine associated with a decreased risk of macrophage activation syndrome among adult patients hospitalized with systemic lupus erythematosus.
    Cohen EM; D'Silva K; Kreps D; Son MB; Costenbader KH
    Lupus; 2018 Jun; 27(7):1065-1071. PubMed ID: 29451069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus.
    Nishino A; Katsumata Y; Kawasumi H; Hirahara S; Kawaguchi Y; Yamanaka H
    Lupus; 2019 Jul; 28(8):986-994. PubMed ID: 31246559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage activation syndrome in adult systemic lupus erythematosus: report of seven adult cases from a single Italian rheumatology center.
    Dall'Ara F; Cavazzana I; Frassi M; Taraborelli M; Fredi M; Franceschini F; Andreoli L; Rossi M; Cattaneo C; Tincani A; Airò P
    Reumatismo; 2018 Jul; 70(2):100-105. PubMed ID: 29976044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of perforin in adult systemic lupus erythematosus associated macrophage activation syndrome: Clinicohematological correlation and literature review.
    Velayutham B; Padhi S; Devi S; Patra S; Panigrahi C; Ramasubbu MK; Kumar R; Raheman S
    Lupus; 2024 Jan; 33(1):26-39. PubMed ID: 38069452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent macrophage activation syndrome as the initial manifestation of paediatric systemic lupus erythematosus.
    Dey S; Roongta R; Mondal S; Haldar S; Sircar G; Ghosh B; Ghosh A
    Lupus; 2022 Aug; 31(9):1132-1137. PubMed ID: 35713230
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical features and correct diagnosis of macrophage activation syndrome.
    Cron RQ; Davi S; Minoia F; Ravelli A
    Expert Rev Clin Immunol; 2015; 11(9):1043-53. PubMed ID: 26082353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication?
    Pringe A; Trail L; Ruperto N; Buoncompagni A; Loy A; Breda L; Martini A; Ravelli A
    Lupus; 2007; 16(8):587-92. PubMed ID: 17711893
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.